Category Archives: Pr Newswire

ecozy Unveils Ultra-Compact Countertop Ice Cube Maker with Dual Water Supply for Seamless Ice Production

This compact countertop ice maker offers flexible ice-making with a built-in tank and a 1.5L external tank, delivering big convenience in a small package. IRVINE, Calif., Sept. 24, 2024 /PRNewswire/ — ecozy, a leading global home appliance brand, proudly introduces its latest innovation: an ultra-compact countertop ice cube maker featuring a dual water supply system. […]

Xinhua Silk Road: National iron, steel industry vocational skills competition kicks off in E. China

BEIJING, Sept. 24, 2024 /PRNewswire/ — A national iron and steel industry vocational skills competition kicked off on Monday in Zhangjiagang City, east China’s Jiangsu Province, aiming to meet the new needs of global sci-tech revolution and industrial transformation and to promote high-quality development of the industry. Photo shows the opening ceremony of a national iron […]

BAI Capital Celebrates Grand Opening of Archer Place, Paving the Way to the American Dream

HO CHI MINH CITY, Vietnam, Sept. 24, 2024 /PRNewswire/ — BAI Capital, a leading real estate investment firm, proudly announces the successful grand opening of Archer Place, a landmark mixed-use development situated in the heart of Gainesville, Florida. Archer Place represents not only a premium real estate investment opportunity but also a gateway for international […]

Highway Holdings Declares $0.02 Cash Dividend per Share; Company Sets Dividend Record and Distribution Dates

HONG KONG, Sept. 24, 2024 /PRNewswire/ — Highway Holdings Limited (Nasdaq: HIHO, “the Company” or “Highway Holdings”) today announced the Company’s Board of Directors declared a cash dividend of $0.02 per common share. The dividend will be paid on October 11, 2024 to shareholders of record on October 4, 2024. Roland Kohl, chairman, president and chief […]

Corero Network Security To Hold Investor Calls Following Strong H1 2024 Results

LONDON, Sept. 24, 2024 /PRNewswire/ — Corero Network Security (AIM: CNS) (OTCQB: DDOSF), the distributed denial of service (DDoS) protection specialists, will hold investor calls this week to discuss its unaudited results for the six months ended 30 June 2024. The calls will be led by Corero’s CEO, Carl Herberger, and newly appointed CFO, Chris […]

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 25, 2024, At 4 pm Eastern Time

Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference. SAN DIEGO, CA, Sept. 23, 2024 (GLOBE NEWSWIRE) — Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA […]

Smart for Life Reports Significant Balance Sheet Improvement; Achieves Over $9.4 Million in Positive Net Stockholders’ Equity Following Successful Restructuring Efforts

Company Files Annual 10-K Report with Full Financial Results MIAMI, Sept. 23, 2024 (GLOBE NEWSWIRE) — Smart for Life, Inc. (OTC: SMFL) (“Smart for Life” or the “Company”), a distinguished leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today announced significant progress in strengthening its […]

DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial

Châtillon, France, September 23, 2024 DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial In Q3 2024, DBV exceeded its recruitment goal and successfully closed the screening process for the VITESSE Phase 3 study evaluating the Viaskin® Peanut Patch in peanut allergic children ages 4 – 7 years old Topline results of VITESSE […]

BioVie Inc. Announces Proposed Public Offering

CARSON CITY, Nev., Sept. 23, 2024 (GLOBE NEWSWIRE) — BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, today announced that it intends to offer to sell shares of its common stock (and/or pre-funded warrants (“Pre-Funded Warrants”) […]

QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database

QIAGEN chooses Bode Technology as its exclusive global commercial partner to accelerate use of GEDmatch PRO genealogy database in law enforcement and identification of human remains // Collaboration ensures GEDmatch PRO development remains focused on the needs of forensic genealogists and investigators in the U.S. and other countries worldwide // Partnership builds on QIAGEN’s leading […]